Semaglutide is a GLP-1 receptor agonist used for weight loss and blood sugar management, and many people taking it wonder whether they can still donate blood
Semaglutide can break this cycle dramatically
Nutritional interventions, especially increased protein intake, may offer protective effects against muscle loss, though GLP-1 RAs therapies may inadvertently suppress protein-rich food consumption
The primary mechanism for these symptoms is altered gastrointestinal motility rather than changes to digestive enzyme production
The practical goal is to reduce avoidable contributors: titrate thoughtfully rather than racing to the highest dose, avoid unnecessarily rapid weight loss, prioritize adequate protein, perform resistance training to preserve lean tissue, and monitor for iron, zinc, vitamin D, vitamin B12, vitamin A, and other deficiencies when intake is substantially reduced